GSK: Protocol Summaries: Compounds

Quick Search

By Phase:

By Study Type:

By Population:

By Post Marketing Commitment:

By Status:

By Country:

GSK Study ID	Phase	Title	Status
114527	phase 1	A Phase 1, open label, dose characteristic study to investigate the pharmacokinetics, pharmacodynamics, safety, and tolerability of intravenous and subcutaneous doses of GSK2315698A in patients with systemic amyloidosis	Completed